What is the appropriate dose of MiraLAX (polyethylene glycol 3350) for a 2‑year‑old child weighing approximately 12–14 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MiraLAX Dosing for a 2-Year-Old

For a 2-year-old child (12-14 kg), start with 0.8 g/kg/day of polyethylene glycol 3350 (MiraLAX), which translates to approximately 10-11 grams daily (roughly 2 leveled teaspoons or 1 leveled tablespoon), mixed in 4-8 ounces of liquid, given once daily.

Dosing Algorithm

Initial Dose

  • Weight-based calculation: 0.8-1.0 g/kg/day is the evidence-based starting point for children under 2 years 12
  • For a 12 kg child: ~10 grams daily
  • For a 14 kg child: ~11 grams daily

Practical Measurement

Since the standard adult capful is 17 grams 3, this is too much for a toddler. Instead:

  • Use 2 leveled teaspoons (approximately 6.6 grams) to 3 leveled teaspoons (approximately 10 grams) 4
  • Or use 1 leveled tablespoon (approximately 10 grams) 4
  • Leveling the measuring device is critical to avoid dose variability 4

Dose Titration

  • Goal: Achieve 1-2 soft, painless stools per day 1
  • Adjust dose every 3 days based on response 5
  • Effective maintenance range: 0.78-1.1 g/kg/day in children under 24 months 12
  • If diarrhea occurs, reduce the dose immediately—this is the most common side effect and resolves with dose adjustment 1

Evidence Supporting This Recommendation

The most relevant pediatric studies specifically examined children under 2 years of age. A retrospective review of 75 infants and toddlers found that mean effective short-term dose was 1.1 g/kg/day and long-term maintenance was 0.8 g/kg/day, with 85% short-term and 91% long-term success rates 1. Another study of 28 children under 18 months demonstrated 97.6% efficacy with a mean maintenance dose of 0.78 g/kg/day 2.

Safety Profile

PEG 3350 is safe and well-tolerated in this age group 612:

  • Adverse effects are mild and transient
  • Most common: diarrhea (resolves with dose reduction) and transient abdominal discomfort
  • No clinically significant electrolyte abnormalities reported
  • No subjects discontinued therapy due to adverse effects in the key studies 12

Important Clinical Considerations

Administration Tips

  • Mix the powder completely in any beverage—it's unflavored and grit-free 3
  • Ensure adequate fluid intake throughout the day
  • Can be given at any time of day, but consistency helps with adherence

Common Pitfalls to Avoid

  • Don't use the adult capful (17g) as the measuring device for toddlers—this overdoses them
  • Don't use "heaping" measurements—these create significant dose variability (up to 15 grams per tablespoon) 4
  • Don't stop too early—studies show sustained efficacy over 6-11 months of treatment 1
  • Don't ignore diarrhea—immediately reduce dose if loose stools develop

When to Adjust

  • Increase dose if: fewer than 3 bowel movements per week, continued straining, or hard stools persist after 3 days
  • Decrease dose if: diarrhea, more than 3 stools daily, or watery consistency
  • Maximum tested dose: Up to 1.26 g/kg/day has been used safely, though most children respond to lower doses 1

Duration of Therapy

Long-term use is appropriate and safe. The mean duration in pediatric studies was 6-11 months, with some children treated for up to 21 months without adverse effects 12. Adult guidelines support PEG use for at least 6 months 7, and this translates to pediatric practice.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.